Drug Abuse
Case management intervention facilitates entry from needle exchange program into drug abuse program
Published in TB and Outbreaks Week, September 19th, 2006
According to a recently published report from the United States, "We evaluated a case management intervention to increase treatment entry among injecting drug users referred from a needle exchange program (NEP).
"A randomized trial of a strengths based case management (intervention) versus passive referral (control) was conducted among NEP attenders requesting and receiving referrals to subsidized, publicly funded opiate agonist treatment programs in Baltimore, MD."
"Logistic regression identified...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Escherichia Coli Outbreaks
Cefotaxime and ceftazidime resistance Escherichia coli can spread between health facilities - Tuberculosis & Lower Back Pain
Tuberculosis is a common cause of low back pain that is liable to be overlooked - Tuberculosis Predisposition
Autosomal dominant major gene confers pulmonary tuberculosis predisposition in adults - Tuberculosis Risk Factors
High-density dwellings associated with tuberculosis occurrence - Acidobacterium Pathogenesis
Gene encoding Acidobacterium capsulatum major sigma factor identified and characterized - Airborne Virus Detection
Air sampling system detects viruses - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
